| |
| |
|
| Insider
Information: |
Drapkin Kimberlee C |
| Relationship: |
President, CFO and Tre... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 218.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jounce Therapeutics Inc |
JNCE |
President, CFO and Tre... |
2023-05-03 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNCE |
Jounce Therapeutics Inc |
President, CFO and Treasurer |
• – – |
2023-05-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(66,018) |
0 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2023-01-10 |
4 |
S |
$1.12 |
$8,715 |
D/D |
(7,781) |
66,018 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2023-01-09 |
4 |
S |
$1.10 |
$6,947 |
D/D |
(6,315) |
73,799 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
80,114 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2022-01-10 |
4 |
S |
$6.65 |
$54,676 |
D/D |
(8,222) |
52,614 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2022-01-07 |
4 |
S |
$7.30 |
$33,544 |
D/D |
(4,595) |
60,836 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
65,431 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-21 |
4 |
AS |
$12.00 |
$45,588 |
D/D |
(3,799) |
43,181 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-21 |
4 |
OE |
$2.36 |
$8,966 |
D/D |
3,799 |
46,980 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-20 |
4 |
OE |
$0.48 |
$15,217 |
D/D |
13,501 |
69,382 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-20 |
4 |
AS |
$10.03 |
$295,198 |
D/D |
(26,201) |
43,181 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-08 |
4 |
S |
$7.00 |
$21,910 |
D/D |
(3,130) |
55,881 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2021-01-07 |
4 |
S |
$6.76 |
$18,232 |
D/D |
(2,697) |
59,011 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-09-01 |
4 |
AS |
$8.06 |
$58,032 |
D/D |
(7,200) |
61,708 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-08-18 |
4 |
S |
$4.71 |
$3,504 |
D/D |
(744) |
68,908 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-08-17 |
4 |
S |
$4.86 |
$2,206 |
D/D |
(454) |
69,652 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-08-14 |
4 |
S |
$4.64 |
$4,566 |
D/D |
(984) |
70,106 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
71,090 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2020-01-07 |
4 |
S |
$7.78 |
$20,415 |
D/D |
(2,624) |
44,390 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2019-08-16 |
4 |
S |
$3.92 |
$3,991 |
D/D |
(1,018) |
47,014 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2019-08-15 |
4 |
S |
$4.00 |
$2,592 |
D/D |
(648) |
48,032 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2019-08-14 |
4 |
S |
$4.10 |
$2,747 |
D/D |
(670) |
48,680 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
49,350 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2018-08-27 |
4 |
OE |
$2.36 |
$29,972 |
D/D |
12,700 |
27,100 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CFO and Treasurer |
• – – |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
14,400 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
